Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosinopril for Muscle Weakness in COPD
NCT01014338Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Oct 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fosinopril in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started Oct 2009; status: completed.
02
Drugs
fosinopril
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01014338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014338.